Brandywine Global Investment Management LLC Sells 1,318,066 Shares of Kenvue Inc. (NYSE:KVUE)

Brandywine Global Investment Management LLC cut its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 93.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 87,743 shares of the company's stock after selling 1,318,066 shares during the period. Brandywine Global Investment Management LLC's holdings in Kenvue were worth $1,873,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Grove Bank & Trust lifted its stake in shares of Kenvue by 438.4% in the fourth quarter. Grove Bank & Trust now owns 1,163 shares of the company's stock worth $25,000 after buying an additional 947 shares during the last quarter. Geneos Wealth Management Inc. bought a new position in Kenvue in the 4th quarter worth $29,000. SRS Capital Advisors Inc. lifted its position in Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after acquiring an additional 571 shares during the last quarter. Fortitude Family Office LLC boosted its holdings in Kenvue by 106.6% during the fourth quarter. Fortitude Family Office LLC now owns 1,506 shares of the company's stock valued at $32,000 after acquiring an additional 777 shares during the period. Finally, Versant Capital Management Inc grew its position in shares of Kenvue by 300.8% in the fourth quarter. Versant Capital Management Inc now owns 1,920 shares of the company's stock valued at $41,000 after purchasing an additional 1,441 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

KVUE has been the subject of several recent analyst reports. Citigroup decreased their target price on Kenvue from $25.00 to $21.00 and set a "neutral" rating for the company in a research note on Wednesday, January 15th. Canaccord Genuity Group increased their price objective on Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a research report on Wednesday, March 5th. Piper Sandler boosted their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a research report on Monday, February 24th. Barclays increased their price target on shares of Kenvue from $21.00 to $23.00 and gave the company an "equal weight" rating in a report on Thursday, March 27th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Kenvue from a "buy" rating to a "hold" rating and cut their price objective for the company from $25.00 to $24.00 in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $24.00.

Remove Ads

Kenvue Price Performance

Shares of Kenvue stock traded down $1.29 during midday trading on Friday, hitting $22.33. 17,763,957 shares of the company were exchanged, compared to its average volume of 16,812,043. The firm has a 50 day simple moving average of $22.59 and a 200-day simple moving average of $22.46. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The firm has a market cap of $42.68 billion, a P/E ratio of 42.14, a PEG ratio of 2.62 and a beta of 1.25. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.46.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were issued a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.67%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue's payout ratio is currently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.